Prognostic significance of (123)I-mIBG SPECT myocardial imaging in heart failure: differences between patients with ischaemic and non-ischaemic heart failure
The purpose of this study was to examine the prognostic significance of uptake patterns on quantitative myocardial (123)I-mIBG and (99m)Tc-tetrofosmin SPECT imaging in heart failure (HF) subjects and to assess the differences between patients with ischaemic and non-ischaemic HF. Results of quantitat...
Gespeichert in:
Veröffentlicht in: | European heart journal cardiovascular imaging 2016-04, Vol.17 (4), p.384-390 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 390 |
---|---|
container_issue | 4 |
container_start_page | 384 |
container_title | European heart journal cardiovascular imaging |
container_volume | 17 |
creator | Clements, Ian P Kelkar, Anita A Garcia, Ernest V Butler, Javed Chen, Ji Folks, Russell Jacobson, Arnold F |
description | The purpose of this study was to examine the prognostic significance of uptake patterns on quantitative myocardial (123)I-mIBG and (99m)Tc-tetrofosmin SPECT imaging in heart failure (HF) subjects and to assess the differences between patients with ischaemic and non-ischaemic HF.
Results of quantitative analyses of (123)I-mIBG myocardial SPECT, alone and in combination with (99m)Tc tetrofosmin SPECT, were studied in 619 ischaemic (I) and 319 non-ischaemic (NI) HF subjects from the ADMIRE-HF trial. Cardiac and all-cause mortality data for 2-year follow-up were collected in the extension study (ADMIRE-HFX) and were examined in relation to extent and severity of voxel-based defects, the number of myocardial segments with significant dysinnervation (derived score ≥2), and (123)I-mIBG/(99m)Tc tetrofosmin mismatch quantitation. Cox proportional hazards and survival analyses were used to identify higher and lower risk groups and to define thresholds for optimal discrimination between the two. Two-year all-cause and cardiac mortality were not significantly different between IHF and NIHF subjects. Mortality was higher in patients with dysinnervation involving >50% of the myocardium. Highest cardiac mortality risk for IHF subjects was seen with perfusion defects involving 20-40% of the myocardium. By comparison, NIHF subjects with smaller perfusion abnormalities ( |
doi_str_mv | 10.1093/ehjci/jev295 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1774529642</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1774529642</sourcerecordid><originalsourceid>FETCH-LOGICAL-p126t-6d2dbfc2e2f2be75aae933f86fc5ed1885f209a7cc8586657f34d90b2139e2323</originalsourceid><addsrcrecordid>eNpVkE1Lw0AQhhdBbKm9eZY91kNsdjabD29aai0ULFjPYbOZTbYkm5pNLP0x_lcDVsS5vDC8PDM8hNww_575CZ9juVdmvsdPSMQFGYMfRB4EDEZk6tzeH0YEYQDsiowgFHGcxHxMvrZtU9jGdUZRZwprtFHSKqSNpjMG_G7t1eunFX3bLhc7Wp8aJdvcyIqaWhbGFtRYWqJsO6qlqfoWH2hutMYWB4ijGXZHREsPsjNoO0ePpiupcaqUWA8npc2pbaz3t_kHuyaXWlYOp-eckPfn5W7x4m1eV-vF48Y7MAg7L8whz7QCBA0ZRkJKTDjXcaiVwJzFsdDgJzJSKhZxGIpI8yBP_AwYTxA48AmZ_XAPbfPRo-vSevgIq0pabHqXsigKBCSDvaF6e672WY15emgHE-0p_VXKvwECQ3mw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1774529642</pqid></control><display><type>article</type><title>Prognostic significance of (123)I-mIBG SPECT myocardial imaging in heart failure: differences between patients with ischaemic and non-ischaemic heart failure</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Clements, Ian P ; Kelkar, Anita A ; Garcia, Ernest V ; Butler, Javed ; Chen, Ji ; Folks, Russell ; Jacobson, Arnold F</creator><creatorcontrib>Clements, Ian P ; Kelkar, Anita A ; Garcia, Ernest V ; Butler, Javed ; Chen, Ji ; Folks, Russell ; Jacobson, Arnold F</creatorcontrib><description>The purpose of this study was to examine the prognostic significance of uptake patterns on quantitative myocardial (123)I-mIBG and (99m)Tc-tetrofosmin SPECT imaging in heart failure (HF) subjects and to assess the differences between patients with ischaemic and non-ischaemic HF.
Results of quantitative analyses of (123)I-mIBG myocardial SPECT, alone and in combination with (99m)Tc tetrofosmin SPECT, were studied in 619 ischaemic (I) and 319 non-ischaemic (NI) HF subjects from the ADMIRE-HF trial. Cardiac and all-cause mortality data for 2-year follow-up were collected in the extension study (ADMIRE-HFX) and were examined in relation to extent and severity of voxel-based defects, the number of myocardial segments with significant dysinnervation (derived score ≥2), and (123)I-mIBG/(99m)Tc tetrofosmin mismatch quantitation. Cox proportional hazards and survival analyses were used to identify higher and lower risk groups and to define thresholds for optimal discrimination between the two. Two-year all-cause and cardiac mortality were not significantly different between IHF and NIHF subjects. Mortality was higher in patients with dysinnervation involving >50% of the myocardium. Highest cardiac mortality risk for IHF subjects was seen with perfusion defects involving 20-40% of the myocardium. By comparison, NIHF subjects with smaller perfusion abnormalities (<20% of myocardium), but with a large discrepancy between (123)I-mIBG and (99m)Tc tetrofosmin defect sizes, were at highest risk of cardiac death.
Prognostic significance of patterns of (123)I-mIBG and MPI uptake differ between IHF and NIHF subjects. SPECT imaging may provide new insights into underlying disease processes in HF, including the degree of dysinnervation in areas with preserved myocardial perfusion in non-ischaemic HF patients.</description><identifier>EISSN: 2047-2412</identifier><identifier>DOI: 10.1093/ehjci/jev295</identifier><identifier>PMID: 26588983</identifier><language>eng</language><publisher>England</publisher><subject>3-Iodobenzylguanidine ; Aged ; Female ; Follow-Up Studies ; Heart Failure - diagnostic imaging ; Heart Failure - mortality ; Humans ; Male ; Middle Aged ; Myocardial Ischemia - diagnostic imaging ; Myocardial Ischemia - mortality ; Organophosphorus Compounds ; Organotechnetium Compounds ; Prognosis ; Radiopharmaceuticals ; Survival Analysis ; Tomography, Emission-Computed, Single-Photon - methods</subject><ispartof>European heart journal cardiovascular imaging, 2016-04, Vol.17 (4), p.384-390</ispartof><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2015. For permissions please email: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27926,27927</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26588983$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Clements, Ian P</creatorcontrib><creatorcontrib>Kelkar, Anita A</creatorcontrib><creatorcontrib>Garcia, Ernest V</creatorcontrib><creatorcontrib>Butler, Javed</creatorcontrib><creatorcontrib>Chen, Ji</creatorcontrib><creatorcontrib>Folks, Russell</creatorcontrib><creatorcontrib>Jacobson, Arnold F</creatorcontrib><title>Prognostic significance of (123)I-mIBG SPECT myocardial imaging in heart failure: differences between patients with ischaemic and non-ischaemic heart failure</title><title>European heart journal cardiovascular imaging</title><addtitle>Eur Heart J Cardiovasc Imaging</addtitle><description>The purpose of this study was to examine the prognostic significance of uptake patterns on quantitative myocardial (123)I-mIBG and (99m)Tc-tetrofosmin SPECT imaging in heart failure (HF) subjects and to assess the differences between patients with ischaemic and non-ischaemic HF.
Results of quantitative analyses of (123)I-mIBG myocardial SPECT, alone and in combination with (99m)Tc tetrofosmin SPECT, were studied in 619 ischaemic (I) and 319 non-ischaemic (NI) HF subjects from the ADMIRE-HF trial. Cardiac and all-cause mortality data for 2-year follow-up were collected in the extension study (ADMIRE-HFX) and were examined in relation to extent and severity of voxel-based defects, the number of myocardial segments with significant dysinnervation (derived score ≥2), and (123)I-mIBG/(99m)Tc tetrofosmin mismatch quantitation. Cox proportional hazards and survival analyses were used to identify higher and lower risk groups and to define thresholds for optimal discrimination between the two. Two-year all-cause and cardiac mortality were not significantly different between IHF and NIHF subjects. Mortality was higher in patients with dysinnervation involving >50% of the myocardium. Highest cardiac mortality risk for IHF subjects was seen with perfusion defects involving 20-40% of the myocardium. By comparison, NIHF subjects with smaller perfusion abnormalities (<20% of myocardium), but with a large discrepancy between (123)I-mIBG and (99m)Tc tetrofosmin defect sizes, were at highest risk of cardiac death.
Prognostic significance of patterns of (123)I-mIBG and MPI uptake differ between IHF and NIHF subjects. SPECT imaging may provide new insights into underlying disease processes in HF, including the degree of dysinnervation in areas with preserved myocardial perfusion in non-ischaemic HF patients.</description><subject>3-Iodobenzylguanidine</subject><subject>Aged</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart Failure - diagnostic imaging</subject><subject>Heart Failure - mortality</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myocardial Ischemia - diagnostic imaging</subject><subject>Myocardial Ischemia - mortality</subject><subject>Organophosphorus Compounds</subject><subject>Organotechnetium Compounds</subject><subject>Prognosis</subject><subject>Radiopharmaceuticals</subject><subject>Survival Analysis</subject><subject>Tomography, Emission-Computed, Single-Photon - methods</subject><issn>2047-2412</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkE1Lw0AQhhdBbKm9eZY91kNsdjabD29aai0ULFjPYbOZTbYkm5pNLP0x_lcDVsS5vDC8PDM8hNww_575CZ9juVdmvsdPSMQFGYMfRB4EDEZk6tzeH0YEYQDsiowgFHGcxHxMvrZtU9jGdUZRZwprtFHSKqSNpjMG_G7t1eunFX3bLhc7Wp8aJdvcyIqaWhbGFtRYWqJsO6qlqfoWH2hutMYWB4ijGXZHREsPsjNoO0ePpiupcaqUWA8npc2pbaz3t_kHuyaXWlYOp-eckPfn5W7x4m1eV-vF48Y7MAg7L8whz7QCBA0ZRkJKTDjXcaiVwJzFsdDgJzJSKhZxGIpI8yBP_AwYTxA48AmZ_XAPbfPRo-vSevgIq0pabHqXsigKBCSDvaF6e672WY15emgHE-0p_VXKvwECQ3mw</recordid><startdate>201604</startdate><enddate>201604</enddate><creator>Clements, Ian P</creator><creator>Kelkar, Anita A</creator><creator>Garcia, Ernest V</creator><creator>Butler, Javed</creator><creator>Chen, Ji</creator><creator>Folks, Russell</creator><creator>Jacobson, Arnold F</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201604</creationdate><title>Prognostic significance of (123)I-mIBG SPECT myocardial imaging in heart failure: differences between patients with ischaemic and non-ischaemic heart failure</title><author>Clements, Ian P ; Kelkar, Anita A ; Garcia, Ernest V ; Butler, Javed ; Chen, Ji ; Folks, Russell ; Jacobson, Arnold F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p126t-6d2dbfc2e2f2be75aae933f86fc5ed1885f209a7cc8586657f34d90b2139e2323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>3-Iodobenzylguanidine</topic><topic>Aged</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart Failure - diagnostic imaging</topic><topic>Heart Failure - mortality</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myocardial Ischemia - diagnostic imaging</topic><topic>Myocardial Ischemia - mortality</topic><topic>Organophosphorus Compounds</topic><topic>Organotechnetium Compounds</topic><topic>Prognosis</topic><topic>Radiopharmaceuticals</topic><topic>Survival Analysis</topic><topic>Tomography, Emission-Computed, Single-Photon - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Clements, Ian P</creatorcontrib><creatorcontrib>Kelkar, Anita A</creatorcontrib><creatorcontrib>Garcia, Ernest V</creatorcontrib><creatorcontrib>Butler, Javed</creatorcontrib><creatorcontrib>Chen, Ji</creatorcontrib><creatorcontrib>Folks, Russell</creatorcontrib><creatorcontrib>Jacobson, Arnold F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>European heart journal cardiovascular imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Clements, Ian P</au><au>Kelkar, Anita A</au><au>Garcia, Ernest V</au><au>Butler, Javed</au><au>Chen, Ji</au><au>Folks, Russell</au><au>Jacobson, Arnold F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic significance of (123)I-mIBG SPECT myocardial imaging in heart failure: differences between patients with ischaemic and non-ischaemic heart failure</atitle><jtitle>European heart journal cardiovascular imaging</jtitle><addtitle>Eur Heart J Cardiovasc Imaging</addtitle><date>2016-04</date><risdate>2016</risdate><volume>17</volume><issue>4</issue><spage>384</spage><epage>390</epage><pages>384-390</pages><eissn>2047-2412</eissn><abstract>The purpose of this study was to examine the prognostic significance of uptake patterns on quantitative myocardial (123)I-mIBG and (99m)Tc-tetrofosmin SPECT imaging in heart failure (HF) subjects and to assess the differences between patients with ischaemic and non-ischaemic HF.
Results of quantitative analyses of (123)I-mIBG myocardial SPECT, alone and in combination with (99m)Tc tetrofosmin SPECT, were studied in 619 ischaemic (I) and 319 non-ischaemic (NI) HF subjects from the ADMIRE-HF trial. Cardiac and all-cause mortality data for 2-year follow-up were collected in the extension study (ADMIRE-HFX) and were examined in relation to extent and severity of voxel-based defects, the number of myocardial segments with significant dysinnervation (derived score ≥2), and (123)I-mIBG/(99m)Tc tetrofosmin mismatch quantitation. Cox proportional hazards and survival analyses were used to identify higher and lower risk groups and to define thresholds for optimal discrimination between the two. Two-year all-cause and cardiac mortality were not significantly different between IHF and NIHF subjects. Mortality was higher in patients with dysinnervation involving >50% of the myocardium. Highest cardiac mortality risk for IHF subjects was seen with perfusion defects involving 20-40% of the myocardium. By comparison, NIHF subjects with smaller perfusion abnormalities (<20% of myocardium), but with a large discrepancy between (123)I-mIBG and (99m)Tc tetrofosmin defect sizes, were at highest risk of cardiac death.
Prognostic significance of patterns of (123)I-mIBG and MPI uptake differ between IHF and NIHF subjects. SPECT imaging may provide new insights into underlying disease processes in HF, including the degree of dysinnervation in areas with preserved myocardial perfusion in non-ischaemic HF patients.</abstract><cop>England</cop><pmid>26588983</pmid><doi>10.1093/ehjci/jev295</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | EISSN: 2047-2412 |
ispartof | European heart journal cardiovascular imaging, 2016-04, Vol.17 (4), p.384-390 |
issn | 2047-2412 |
language | eng |
recordid | cdi_proquest_miscellaneous_1774529642 |
source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection |
subjects | 3-Iodobenzylguanidine Aged Female Follow-Up Studies Heart Failure - diagnostic imaging Heart Failure - mortality Humans Male Middle Aged Myocardial Ischemia - diagnostic imaging Myocardial Ischemia - mortality Organophosphorus Compounds Organotechnetium Compounds Prognosis Radiopharmaceuticals Survival Analysis Tomography, Emission-Computed, Single-Photon - methods |
title | Prognostic significance of (123)I-mIBG SPECT myocardial imaging in heart failure: differences between patients with ischaemic and non-ischaemic heart failure |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T07%3A14%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20significance%20of%20(123)I-mIBG%20SPECT%20myocardial%20imaging%20in%20heart%20failure:%20differences%20between%20patients%20with%20ischaemic%20and%20non-ischaemic%20heart%20failure&rft.jtitle=European%20heart%20journal%20cardiovascular%20imaging&rft.au=Clements,%20Ian%20P&rft.date=2016-04&rft.volume=17&rft.issue=4&rft.spage=384&rft.epage=390&rft.pages=384-390&rft.eissn=2047-2412&rft_id=info:doi/10.1093/ehjci/jev295&rft_dat=%3Cproquest_pubme%3E1774529642%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1774529642&rft_id=info:pmid/26588983&rfr_iscdi=true |